Business Description
Shandong Buchang Pharmaceuticals Co Ltd
ISIN : CNE100002FV6
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.34 | |||||
Equity-to-Asset | 0.55 | |||||
Debt-to-Equity | 0.34 | |||||
Debt-to-EBITDA | -59.23 | |||||
Interest Coverage | 6.32 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 2.36 | |||||
Beneish M-Score | -2.75 | |||||
WACC vs ROIC |
Growth Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -6.1 | |||||
3-Year EBITDA Growth Rate | -27.9 | |||||
3-Year EPS without NRI Growth Rate | -44.5 | |||||
3-Year Book Growth Rate | -4.3 |
Momentum Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 46.85 | |||||
9-Day RSI | 42.94 | |||||
14-Day RSI | 43.76 | |||||
6-1 Month Momentum % | 9.6 | |||||
12-1 Month Momentum % | 0.66 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.24 | |||||
Quick Ratio | 0.51 | |||||
Cash Ratio | 0.22 | |||||
Days Inventory | 366.93 | |||||
Days Sales Outstanding | 37.74 | |||||
Days Payable | 186.12 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 0.77 | |||||
Dividend Payout Ratio | 0.31 | |||||
3-Year Dividend Growth Rate | -15.9 | |||||
Forward Dividend Yield % | 0.77 | |||||
5-Year Yield-on-Cost % | 0.35 | |||||
3-Year Average Share Buyback Ratio | 1 | |||||
Shareholder Yield % | -1.84 |
Profitability Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 59.75 | |||||
Operating Margin % | 6.43 | |||||
Net Margin % | -2.49 | |||||
FCF Margin % | 4.97 | |||||
ROE % | -2.53 | |||||
ROA % | -1.41 | |||||
ROIC % | 13.22 | |||||
ROC (Joel Greenblatt) % | -0.93 | |||||
ROCE % | -0.45 | |||||
Years of Profitability over Past 10-Year | 9 |
GF Value Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio without NRI | 41.02 | |||||
Shiller PE Ratio | 12.37 | |||||
PS Ratio | 1.55 | |||||
PB Ratio | 1.63 | |||||
Price-to-Tangible-Book | 2.5 | |||||
Price-to-Free-Cash-Flow | 30.69 | |||||
Price-to-Operating-Cash-Flow | 19.63 | |||||
EV-to-EBIT | -309.88 | |||||
EV-to-EBITDA | -309.88 | |||||
EV-to-Revenue | 1.7 | |||||
EV-to-FCF | 35.33 | |||||
Price-to-Projected-FCF | 0.97 | |||||
Price-to-Graham-Number | 2.14 | |||||
Earnings Yield (Greenblatt) % | -0.32 | |||||
FCF Yield % | 3.21 | |||||
Forward Rate of Return (Yacktman) % | 4.63 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Shandong Buchang Pharmaceuticals Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ¥) | 11,776.314 | ||
EPS (TTM) (Â¥) | -0.26 | ||
Beta | 1.04 | ||
Volatility % | 30.17 | ||
14-Day RSI | 43.76 | ||
14-Day ATR (Â¥) | 0.309928 | ||
20-Day SMA (Â¥) | 16.7795 | ||
12-1 Month Momentum % | 0.66 | ||
52-Week Range (Â¥) | 14.15 - 19.7 | ||
Shares Outstanding (Mil) | 1,106.04 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Shandong Buchang Pharmaceuticals Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Shandong Buchang Pharmaceuticals Co Ltd Stock Events
Event | Date | Price(Â¥) | ||
---|---|---|---|---|
No Event Data |
Shandong Buchang Pharmaceuticals Co Ltd Frequently Asked Questions
What is Shandong Buchang Pharmaceuticals Co Ltd(SHSE:603858)'s stock price today?
When is next earnings date of Shandong Buchang Pharmaceuticals Co Ltd(SHSE:603858)?
Does Shandong Buchang Pharmaceuticals Co Ltd(SHSE:603858) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |